Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
II
116TH CONGRESS
2D SESSION
S. 3715
To amend the Defense Production Act of 1950 to ensure the supply of
certain medical articles essential to national defense, and for other purposes.
IN THE SENATE OF THE UNITED STATES
MAY 13, 2020
Ms. MCSALLY (for herself and Mr. CRAMER) introduced the following bill;
which was read twice and referred to the Committee on Banking, Hous-
ing, and Urban Affairs
A BILL
To amend the Defense Production Act of 1950 to ensure
the supply of certain medical articles essential to national
defense, and for other purposes.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Securing America’s
4
Vaccines for Emergencies Act of 2020’’ or the ‘‘SAVE Act
5
of 2020’’.
6
VerDate Sep 11 2014
15:43 Jun 02, 2020
Jkt 099200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\S3715.IS
S3715
pamtmann on DSKBC07HB2PROD with BILLS
2
•S 3715 IS
SEC. 2. SECURING ESSENTIAL MEDICAL ARTICLES.
1
(a) STATEMENT OF POLICY.—Section 2(b) of the De-
2
fense Production Act of 1950 (50 U.S.C. 4502(b)) is
3
amended—
4
(1) by redesignating paragraphs (3) through
5
(8) as paragraphs (4) through (9), respectively; and
6
(2) by inserting after paragraph (2) the fol-
7
lowing:
8
‘‘(3) authorities under this Act should be used
9
when appropriate to ensure the availability of med-
10
ical articles essential to national defense, including
11
through measures designed to secure the drug sup-
12
ply chain, and taking into consideration the impor-
13
tance of United States competitiveness, scientific
14
leadership and cooperation, and innovative capac-
15
ity;’’.
16
(b) STRENGTHENING DOMESTIC CAPABILITY.—Sec-
17
tion 107 of the Defense Production Act of 1950 (50
18
U.S.C. 4517) is amended—
19
(1) in subsection (a), by striking ‘‘and indus-
20
trial resources’’ and inserting ‘‘industrial resources,
21
and medical articles’’; and
22
(2) in subsection (b)(1), by striking ‘‘and indus-
23
trial resources’’ and inserting ‘‘industrial resources,
24
and medical articles (including drugs to diagnose,
25
VerDate Sep 11 2014
15:43 Jun 02, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\S3715.IS
S3715
pamtmann on DSKBC07HB2PROD with BILLS
3
•S 3715 IS
cure, mitigate, treat, or prevent disease) essential to
1
national defense’’.
2
(c) STRATEGY ON SECURING SUPPLY CHAINS FOR
3
MEDICAL ARTICLES.—Title I of the Defense Production
4
Act of 1950 (50 U.S.C. 4511 et seq.) is amended by add-
5
ing at the end the following:
6
‘‘SEC. 109. STRATEGY ON SECURING SUPPLY CHAINS FOR
7
MEDICAL ARTICLES.
8
‘‘(a) IN GENERAL.—Not later than 120 days after
9
the date of the enactment of this section, the President,
10
in consultation with the Secretary of Health and Human
11
Services, the Secretary of Commerce, the Secretary of
12
Homeland Security, and the Secretary of Defense, shall
13
transmit a strategy to the appropriate Members of Con-
14
gress that includes the following:
15
‘‘(1) A detailed plan to use the authorities
16
under this title and title III, or any other provision
17
of law, to ensure the supply of medical articles (in-
18
cluding drugs to diagnose, cure, mitigate, treat, or
19
prevent disease) essential to national defense, to the
20
extent necessary for the purposes of this Act.
21
‘‘(2) An analysis of vulnerabilities to existing
22
supply chains for such medical articles, and rec-
23
ommendations to address the vulnerabilities.
24
VerDate Sep 11 2014
15:43 Jun 02, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\S3715.IS
S3715
pamtmann on DSKBC07HB2PROD with BILLS
4
•S 3715 IS
‘‘(3) Measures to be undertaken by the Presi-
1
dent to diversify such supply chains, as appropriate
2
and as required for national defense.
3
‘‘(4) A discussion of—
4
‘‘(A) any significant effects resulting from
5
the plan and measures described in this sub-
6
section on the production, cost, or distribution
7
of vaccines or any other drugs (as defined
8
under section 201 of the Federal Food, Drug,
9
and Cosmetic Act (21 U.S.C. 321));
10
‘‘(B) a timeline to ensure that essential
11
components of the supply chain for medical ar-
12
ticles are not under the exclusive control of a
13
foreign government in a manner that the Presi-
14
dent determines could threaten the national de-
15
fense of the United States; and
16
‘‘(C) efforts to mitigate any risks resulting
17
from the plan and measures described in this
18
subsection to United States competitiveness,
19
scientific leadership, and innovative capacity,
20
including efforts to cooperate and proactively
21
engage with United States allies.
22
‘‘(b) PROGRESS REPORT.—Following submission of
23
the strategy under subsection (a), the President shall sub-
24
mit to the appropriate Members of Congress an annual
25
VerDate Sep 11 2014
15:43 Jun 02, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\S3715.IS
S3715
pamtmann on DSKBC07HB2PROD with BILLS
5
•S 3715 IS
progress report evaluating the implementation of the
1
strategy, and may include updates to the strategy as ap-
2
propriate. The strategy and progress reports shall be sub-
3
mitted in unclassified form but may contain a classified
4
annex.
5
‘‘(c) APPROPRIATE MEMBERS OF CONGRESS.—The
6
term ‘appropriate Members of Congress’ means—
7
‘‘(1) the Speaker, majority leader, and minority
8
leader of the House of Representatives;
9
‘‘(2) the majority leader and minority leader of
10
the Senate;
11
‘‘(3) the chairman and ranking member of the
12
Committee on Financial Services of the House of
13
Representatives; and
14
‘‘(4) the chairman and ranking member of the
15
Committee on Banking, Housing, and Urban Affairs
16
of the Senate.’’.
17
SEC. 3. INVESTMENT IN SUPPLY CHAIN SECURITY.
18
(a) IN GENERAL.—Section 303 of the Defense Pro-
19
duction Act of 1950 (50 U.S.C. 4533) is amended by add-
20
ing at the end the following:
21
‘‘(h) INVESTMENT IN SUPPLY CHAIN SECURITY.—
22
‘‘(1) IN GENERAL.—The President may make
23
available to an eligible entity described in paragraph
24
(2) payments to increase the security of supply
25
VerDate Sep 11 2014
15:43 Jun 02, 2020
Jkt 099200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\S3715.IS
S3715
pamtmann on DSKBC07HB2PROD with BILLS
6
•S 3715 IS
chains and supply chain activities, if the President
1
certifies to Congress not less than 30 days before
2
making such a payment that the payment is impor-
3
tant to meet national defense requirements of the
4
United States.
5
‘‘(2) ELIGIBLE ENTITY.—An eligible entity de-
6
scribed in this paragraph is an entity that—
7
‘‘(A) is organized under the laws of the
8
United States or any jurisdiction within the
9
United States; and
10
‘‘(B) produces—
11
‘‘(i) one or more critical components;
12
‘‘(ii) critical technology; or
13
‘‘(iii) one or more products for the in-
14
creased security of supply chains or supply
15
chain activities.
16
‘‘(3) DEFINITIONS.—In this subsection, the
17
terms ‘supply chain’ and ‘supply chain activities’
18
have the meanings given those terms by the Presi-
19
dent by regulation.’’.
20
(b) REGULATIONS.—
21
(1) IN GENERAL.—Not later than 90 days after
22
the date of the enactment of this Act, the President
23
shall prescribe regulations setting forth definitions
24
for the terms ‘‘supply chain’’ and ‘‘supply chain ac-
25
VerDate Sep 11 2014
15:43 Jun 02, 2020
Jkt 099200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\S3715.IS
S3715
pamtmann on DSKBC07HB2PROD with BILLS
7
•S 3715 IS
tivities’’ for the purposes of subsection (h) of section
1
303 of the Defense Production Act of 1950 (50
2
U.S.C. 4533), as added by subsection (a).
3
(2) SCOPE OF DEFINITIONS.—The definitions
4
required by paragraph (1)—
5
(A) shall encompass—
6
(i) the organizations, people, activi-
7
ties, information, and resources involved in
8
the delivery and operation of a product or
9
service used by the Government; or
10
(ii) critical infrastructure as defined
11
in Presidential Policy Directive 21 (Feb-
12
ruary 12, 2013; relating to critical infra-
13
structure security and resilience); and
14
(B) may include variations as determined
15
necessary and appropriate by the President for
16
purposes of national defense.
17
Æ
VerDate Sep 11 2014
15:43 Jun 02, 2020
Jkt 099200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6301
E:\BILLS\S3715.IS
S3715
pamtmann on DSKBC07HB2PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.